Education
About Us
Working with TipRanks
Follow Us
Orthocell Ltd (AU:OCC)
:OCC
OCC Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.40 - AU$1.79
Previous CloseN/A
Volume2.26M
Average Volume (3M)402.11K
Market Cap
AU$279.55M
Enterprise ValueAU$257.89M
Total Cash (Recent Filing)AU$28.62M
Total Debt (Recent Filing)AU$576.89K
Price to Earnings (P/E)―
Beta1.28
Next Earnings
Mar 03, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding246,300,000
10 Day Avg. Volume379,326
30 Day Avg. Volume402,112
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$1.50Price Target Upside32.74% Upside
Rating ConsensusHold
Number of Analyst Covering0
Orthocell Ltd News
OCC FAQ
What was Orthocell Ltd’s price range in the past 12 months?
Orthocell Ltd lowest share price was AU$0.40 and its highest was AU$1.79 in the past 12 months.
What is Orthocell Ltd’s market cap?
Orthocell Ltd’s market cap is AU$279.55M.
When is Orthocell Ltd’s upcoming earnings report date?
Orthocell Ltd’s upcoming earnings report date is Mar 03, 2026 which is in 178 days.
How were Orthocell Ltd’s earnings last quarter?
Orthocell Ltd released its earnings results on Aug 28, 2025. The company reported -AU$0.03 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.03.
Is Orthocell Ltd overvalued?
According to Wall Street analysts Orthocell Ltd’s price is currently Undervalued.
Does Orthocell Ltd pay dividends?
Orthocell Ltd does not currently pay dividends.
What is Orthocell Ltd’s EPS estimate?
Orthocell Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Orthocell Ltd have?
Orthocell Ltd has 246,300,000 shares outstanding.
What happened to Orthocell Ltd’s price movement after its last earnings report?
Orthocell Ltd reported an EPS of -AU$0.03 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Orthocell Ltd?
Currently, no hedge funds are holding shares in AU:OCC
Orthocell Ltd Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
AU$1.50 (32.74% Upside)
AU$1.50 (32.74% Upside)
Blogger Sentiment
Bullish
AU:OCC Sentiment 70%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
189.74%
12-Months-Change
Fundamentals
Return on Equity
-89.70%
Trailing 12-Months
Asset Growth
32.39%
Trailing 12-Months
Company Description
Orthocell Ltd
Orthocell Ltd (OCC) is an Australian-based regenerative medicine company specializing in the development and commercialization of cell therapies and related technologies for the repair and regeneration of soft tissue injuries. The company's core products include CelGro, a collagen-based scaffold for tissue repair, and autologous cell therapy solutions such as Ortho-ATI and Ortho-ACI, which are designed to treat musculoskeletal conditions and cartilage injuries. Orthocell operates within the biotechnology and healthcare sectors, focusing on innovative solutions to improve patient outcomes.
Technical Analysis
Paradigm Biopharmaceuticals
―
Immutep Ltd
―
Dimerix Limited
―
Recce Pharmaceuticals Ltd.
―
Arovella Therapeutics Limited
―
Ownership Overview
3.16% Insiders
―
Mutual Funds
― Other Institutional Investors
96.71% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---